Tero Aittokallio

Improved detection of differentially represented DNA barcodes for high-throughput clonal phenomics (2020)

Molecular Systems Biology

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening (2020)

Bioinformatics

Swapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, Dmitrii Bychkov, Clément Fiere, Philipp Ianevski, Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, Olli Kallioniemi, Jani Saarela, Päivi Östling

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis (2020)

Cancer Research

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)

Scientific Data

Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytkönen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Multiobjective optimization identifies cancer-selective combination therapies (2020)

PLoS Computational Biology

Pulkkinen Otto I, Gautam Prson, Mustonen Ville, Aittokallio Tero

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine (2020)

Leukemia

(B1 Kirjoitus tieteellisessä aikakauslehdessä)

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening (2020)

Communications Biology

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity (2020)

Blood

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses (2020)

Leukemia

Shady Adnan Awad, Olli Dufva, Aleksandr Ianevski, Bishwa Ghimire, Jan Koski, Pilvi Maliniemi, Daniel Thomson, Andreas Schreiber, Caroline A. Heckman, Perttu Koskenvesa, Matti Korhonen, Kimmo Porkka, Susan Branford, Tero Aittokallio, Matti Kankainen, Satu Mustjoki

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets (2020)

International Journal of Medical Informatics

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Improved detection of differentially represented DNA barcodes for high-throughput clonal phenomics (2020)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening (2020)

UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis (2020)

A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)

Multiobjective optimization identifies cancer-selective combination therapies (2020)

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine (2020)

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening (2020)

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity (2020)

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses (2020)

Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets (2020)